Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2807
+0.0022 (0.79%)
Apr 28, 2025, 9:43 AM EDT - Market open
Cyclacel Pharmaceuticals Employees
Cyclacel Pharmaceuticals had 12 employees as of December 31, 2019. The number of employees decreased by 2 or -14.29% compared to the previous year.
Employees
12
Change (1Y)
-2
Growth (1Y)
-14.29%
Revenue / Employee
$3,583
Profits / Employee
-$934,333
Market Cap
58.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CYCC News
- 25 days ago - Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - GlobeNewsWire
- 2 months ago - Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - GlobeNewsWire